Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
December 3, 2017
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Cardiometabolic Health Congress (CMHC)

Who Best to STEM the Cardiometabolic Tsunami: Cardiology, Endocrinology ...

Thu, Nov 19, 2020
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

16:57
William White

Ambulatory Blood Pressure Monitoring

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...

Feat. R. Mason
18:25
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

09:38
George Bakris

Hyperkalemia in Chronic Kidney Disease

10:03
Scripps Health: 2019 Updates in Diabetes Management

Multi-specialty Approach to Diabetes, Discussion with Nephrology

Feat. K. Harper
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...

18:43
Bonita Falkner

Recent Advances in Pediatric Hypertension

28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth
16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
19:24
Cardiometabolic Health Congress (CMHC)

2020 Update on LDL-C Reduction: Does Aggressive LDL-C Lowering Therapy E...

Feat. P. Taub
04:42
Cleveland Clinic Heart, Vascular and Thoracic Institute

Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial

Feat. S. Nissen
16:40
Houston Methodist DeBakey Heart and Vascular Center

Update on Inflammation & Atherosclerosis Treatment: Should All Atheroscl...

Feat. P. Ridker
10:16
Emory Diabetes Education Training Academy

Standards of Diabetes Care: Cardiovascular Disease and Risk Management

Feat. G. Umpierrez
23:46
National Lipid Association

What is the Role of Statins in Viral Pandemics? Immunomodulatory and Car...

Feat. S. Ravilla
11:06
Cardiometabolic Health Congress (CMHC)

ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC in HFrE...

Feat. S. Wiviott